Raw Materials for Cell and Gene Therapy Summit

Topics

• Enabling Alignment & Streamlining Material Control Strategies Through Understanding Regulatory Definitions & Classifications of Raw & Starting Materials for Cell & Gene Therapies
• Achieving Higher Safety & Quality of Raw Materials Through Reliable Manufacturing & Testing Strategies to Ensure Production of High-Quality Cell & Gene Therapies
• Unlocking Release & Stability Testing Strategies for Master Cell Banks (MCBs) & Working Cell Banks (WCBs) to Prove Efficiency & Biological Effect of Your Raw Materials
• Evaluating the Latest Innovations in Analytical Characterization & Stability Testing of Raw Materials for Cell & Gene Therapies Manufacturing in Line with Regulatory Expectations
• Improving Final Drug Product Quality Through Sourcing & Characterizing Safe & Premium Raw Materials Used in Cell & Gene Therapy Development Process
• De-Risking Raw Materials Safety & Reliability Through Understanding Key Considerations for High-Risk Human Derived Materials & Single-Use Systems
• Establishing Regulatory Compliance by Streamlining Supply Chain & GMP Manufacturing of Your Raw Materials to Develop Scalable Cell & Gene Therapies